Form 3 Adult Discharge Audit Case Report Form

P Form Approved OMB No. 0920-08AB Exp. Date xx/xx/20xx atient Identifiers and Other Information

Last Name: ___________________________

First Name: ___________________________

Spouse’s Name: _____________________________

Spouse’s Name: ___________________________

Phone No.: ___________________________

Chart Number: ___________________________

Additional Numeric ID: _____________________________

Additional Numeric ID: ___________________________

Address: _________________________________________________________

City: _____________________________

Zip: ___________________________

Open text field for site use: ­­­­­­­­­­­­­­­­­ _______________________________________________________________________________________________________________________

Name of person reporting this case:

Last Name: ___________________________

First Name: _____________________________

Date Reported: ______-______-__________ MM-DD-YYYY

Enrollment Information

1. State (residence of patient): ____ ____

2. County: _____________________________

3. Case I.D.: ____ ____ ____ ____ ____ ____ ____ ____ ____ ____ ____

4. Hospital I.D. Where Patient Treated: ____ ____ ____ ____ ____

a) Admission Date: ______-______-_______ (MM-DD-YYYY) b) Discharge Date: ______-______-_______ (MM-DD-YYYY)

5. Was patient transferred from another hospital:

 Yes

 No

a) If YES, Hospital I.D.: ____ ____ ____ ____ ____

b) Admission Date: ______-______-________ (MM-DD-YYYY) c) Transfer Date: ______-______-________ (MM-DD-YYYY)

6. Was patient a resident of nursing home or other chronic care facility prior to hospitalization?

 Yes

 No

a) If YES, indicate name of facility: _______________________________

7. Date of Birth: _____-_____-_________ (MM-DD-YYYY)

8. Sex:  Male  Female

9. Ethnicity:

10. Race (check all that apply):  White  Asian  Black or African American  Native Hawaiian or Other Pacific Islander  American Indian or Alaska Native  Not Specified

 Hispanic or Latino

 Non-Hispanic or Latino

 Not Specified

POSITIVE Laboratory Testing Results for Influenza

1. How was the diagnosis of influenza confirmed (check all positive tests for influenza):



Fluorescent antibody (Direct or Indirect FA)



RT-PCR



Viral culture



Test method unknown



Rapid Influenza test

2. Was a positive influenza test result noted in the admission H&P or discharge note?

 Yes

 No

3. Hospital/lab/office ID where positive flu test was performed (If done in doctor’s office, use the code MDTST): _____ _____ _____ _____ _____

4. Date of first positive influenza test: _____-_____-_______ (MM-DD-YYYY)

5. Influenza virus identification (check only one type):

 Influenza A

 Influenza B

 Type unknown

a) If Influenza A subtype, please specify if known: ___________________________________________________________________________ _____________________________________________________________

F rom the face sheet, list ICD-9 discharge diagnoses (if available)

1.

.

4.

.

7.

.

2.

.

5.

.

8.

.

3.

.

6.

.

9.

.

From the Admission History and Physical

1. Date of onset of acute illness episode resulting in hospitalization : ______-______-________ (MM-DD-YYYY)

2. Did the patient have any of the following conditions?

 Yes

 No

a) If YES, please check all that apply:

 Asthma (including reactive airway disease)

 Immunosuppressive condition

 Cystic fibrosis

 Seizure disorder

 Other chronic lung disease (Specify)____________________________________________

 History of Guillain-Barre Syndrome

 Chronic cardiovascular disease (Specify)____________________________________________

 History of lymphoma, leukemia

 Chronic metabolic disease (including Diabetes) (Specify) ___________________________________________

 Cognitive dysfunction

 Renal disease (Specify) ___________________________________________

 Pregnant (Specify gestational age in weeks): ____ ____

 Hemoglobinopathy (including Sickle Cell Disease)

 Neuromuscular disorder (including Cerebral Palsy) (Specify) ___________________________________________

 Cancer diagnosis in last 12 months, excluding nonmelanoma skin cancer

Tests, Procedures, and Interventions during the Hospital Stay

1. Chest X-Ray/CT (any during admission)

 Yes

 No

a) If YES, was there a new infiltrate or consolidation?

 Yes

 No

2. Mechanical ventilation

 Yes

 No

Culture Confirmation of Secondary Bacterial Pathogens

1. Was there culture confirmation of an invasive bacterial infection (sterile site)?

 Yes

 No

2. Date of first positive culture ______-______-________ (MM-DD-YYYY)

3. Specify the pathogen identified (check only one):

 Streptococcus pneumoniae

 Staphylococcus aureus:

If YES, methicillin resistant (MRSA)?

 Yes

 No

 Unknown

 Group A Streptococcus

 Neisseria meningitidis (specify serogroup if known):_________________

 Haemophilus influenzae:

If YES, type b?

 Yes

 No

 Unknown

4. Specify the site(s) in which the pathogen was identified (check all that apply):

 Blood

 Pleural fluid

 Cerebrospinal fluid (CSF)

Please specify any other sterile sites not listed above:_________________________________________________________________________

5. If other pathogens were isolated from sterile sites within 2 days of hospital admission, please list below and specify first culture date and sterile site in which pathogen was identified: ________________________________________________________________________________________

Use of Statins (cholesterol lowering medicine)

1. Was the patient taking a statin before hospital admission? (check only one)

 Yes

 No

 Unknown

a

If YES, specify name of statin (enter code): _________

2. Did the patient receive statins any time during hospitalization? (check only one)

 Yes

 No

 Unknown

a

If YES, specify name of statin (enter code): _________

Treatment of Influenza

1. Did the patient receive treatment with an antiviral medication for influenza at any time during the course of this illness?

 Yes

 No

a. If YES, indicate which antiviral medication was used for treatment:

 Amantadine (Symmetrel)

 Zanamivir (Relenza)

 Rimantadine (Flumadine)

 Oseltamivir (Tamiflu)

 Unknown

b. Was antiviral treatment started before hospital admission?

 Yes  No  Unknown

c. Indicate antiviral treatment start date: ____-____-______ (MM-DD-YYYY)  Unknown

From the Discharge Summary

1. Was this patient admitted to an intensive care unit (ICU)?

 Yes

 No

2. Did the patient have any of the following diagnoses at discharge (check all that apply)?

Pneumonia

Yes

No

Stroke (CVA)

Yes

No

Acute encephalopathy/encephalitis

Yes

No

3. What was the outcome of the patient?



Died



Alive

a)

If discharged alive, please indicate to where:



Home



Other hospital



Long-term care facility / rehabilitation center



Hospice



Other



Unknown

Case Identification Method

1. What is the case identification method (check only one)?



Initial Surveillance



Discharge data audit

If Initial Surveillance, specify case finding source (check all that apply):

 Hospital log

 Laboratory list

 Reportable disease

If other case finding sources were used, please list: ____________________________________________________________

Influenza Vaccination History

1. Did the patient receive any influenza vaccine during fall or winter of the current influenza season?

 Yes

 No

 Unknown

2. If YES, please specify vaccine type:  Injected vaccine --Trivalent inactivated influenza vaccine (TIV)  Nasal spray -- Live-attenuated influenza vaccine (LAIV)  Unknown

3. What was the source of vaccination history (check all that apply)?

 Medical chart

Primary care provider

Interview

a) If vaccination history obtained by phone interview, specify source of interview:

Patient

Proxy

Specify relationship (enter code): ___

Public reporting burden of this collection of information is estimated to average 45 minutes per response, including the time for reviewing instructions, searching existing data sources, gathering and maintaining the data needed, and completing and reviewing the collection of information.  An agency may not conduct or sponsor, and a person is not required to respond to a collection of information unless it displays a currently valid OMB control number.  Send comments regarding this burden estimate or any other aspect of this collection of information, including suggestions for reducing this burden to CDC/ATSDR Information Collection Review Office, 1600 Clifton Road NE, MS D-74, Atlanta, Georgia 30333; ATTN: PRA (0920-08AB)